AFMS Collaborates With IIT Delhi To Develop Medical Devices

New Delhi: Armed Forces Medical Services and IIT-Delhi on Monday joined hands to undertake collaborative research to develop novel medical devices and focus on solving health issues specific to serving soldiers in varied terrains.

AFMS signed a Memorandum of Understanding (MoU) for collaborative research and training with the Indian Institute of Technology-Delhi.

“The scope of this MoU includes undertaking research and innovation to develop novel medical devices and focus on solving health issues specific to serving soldiers in varied terrains,” the defence ministry said in a statement.

The MoU was signed by Director General, Armed Forces Medical Services, Lt Gen Daljit Singh and Director, IIT-Delhi, Prof. Rangan Banerjee.

IIT-Delhi has a robust biomedical research ecosystem which is ideal for providing the technical expertise required for research in the diverse medical challenges faced in the armed forces, including rehabilitation of amputees, officials said.

Under the ambit of this agreement, faculty exchange programmes, joint academic activities and development of joint PhD programmes will also be planned, they said.On this occasion, Lt Gen Singh said AFMS is dedicated to providing the highest level of medical care to soldiers and collaboration with institutes of national importance like IITs is a significant step towards this commitment.

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick